Now, it’s worth noting Stock Advisor's total average return is 1,046% — a market-crushing outperformance compared to 191% for ...

These companies have exceptional dividend track records. AbbVie is moving on from its Humira patent losses, and its portfolio ...

Dividend Kings are the crème de la crème of dividend growers and should be top of mind for any investor who puts income ...

Biotech stocks have performed well this year. The SPDR S&P Biotech ETF -- an industry benchmark -- is up 21% this year. Two ...

These dividend ETFs are idea for investors looking for significant yield and capital appreciation over the long-term.

Our popular Dividend Tracker service, Income Calendar, has surpassed $1 Billion in linked assets. JERICHO, NY / ACCESS Newswire / July 23, 2025 / BNK Invest Inc. today announces that our popular ...

Pentair is only one year away from potentially becoming a Dividend King. The stock's performance has beaten the S&P 500 hands down over the last five years. Pentair could be appealing to investors ...

It should go without saying at this point that artificial intelligence isn’t just reshaping the tech landscape, it’s ...

ProShares S&P 500 Dividend Aristocrats ETF's (NOBL) dividend strategy may no longer be effective. Explore six superior ...

Pfizer's Q3 earnings fell, but the company still raised its full-year earnings guidance. Major cost reductions remain on ...